About ADL

This author has not yet filled in any details.
So far ADL has created 32 blog entries.

Lantern Pharma Appoints David Margrave as Chief Financial Officer and Kishor Bhatia, Ph.D., as Chief Scientific Officer

By |2020-07-08T23:34:04+00:00December 17th, 2019|

Appointments bolster executive leadership by adding decades of collective and accomplished experience in fundraising, operational and scientific leadership and oncology research DALLAS and KEARNY, N.J., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Lantern Pharma, a clinical stage oncology biotech leveraging AI and genomics, announced today the appointment of David Margrave as Chief Financial Officer and Kishor [...]

Lantern Pharma Expands and Strengthens Board of Directors with Healthcare and Pharma Industry Veterans Franklyn Prendergast, MD, Ph.D. and Vijay Chandru, Ph.D.

By |2020-02-19T15:12:48+00:00December 16th, 2019|

Lantern Pharma Press Release Lantern Pharma Expands and Strengthens Board of Directors with Healthcare and Pharma Industry Veterans Franklyn Prendergast, MD, Ph.D. and Vijay Chandru, Ph.D.   DALLAS and KEARNY, N.J., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Lantern Pharma, a clinical stage oncology biotech leveraging AI and genomics, announced today the appointment of [...]

Lantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments

By |2019-10-02T13:26:23+00:00October 2nd, 2019|

Lantern Press Release October 01, 2019 08:00 ETLantern Pharma and National Cancer Institute Partner to Aid Precision Oncology Research and Treatments Collaboration will leverage Lantern’s proprietary AI platform and NCI’s platform to better predict patients’ tumor responses to specific drug classes and therapeutics DALLAS and KEARNY, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- [...]

Lantern Pharma CEO Panna Sharma to Showcase AI Platform at Drug Repositioning, Repurposing and Rescue Conference

By |2019-09-18T13:33:59+00:00September 18th, 2019|

Lantern Pharma Press Release Lantern Pharma CEO Panna Sharma to Showcase AI Platform at Drug Repositioning, Repurposing and Rescue Conference September 18, 2019 08:00 ET | Source: Lantern Pharma Presentation to highlight use of machine learning, genomics and AI in building Lantern's oncology drug portfolio and in developing insights about biological mechanisms, biomarker signatures and [...]

Lantern Pharma Chief Scientific Officer Gregory Tobin to Speak at TMED 10: Disruptive Innovation in Healthcare Conference

By |2019-09-04T18:13:28+00:00September 4th, 2019|

Lantern Pharma Press Release Lantern Pharma Chief Scientific Officer Gregory Tobin to Speak at TMED 10: Disruptive Innovation in Healthcare Conference Dr. Tobin will discuss the role of genomic biomarkers and signatures in the development of Lantern’s portfolio of oncology therapeutics at a leading international conference in translational and personalized medicine.  Press Release [...]